SCHEMBL17554172

SCHEMBL17554172

COc1ccc(-c2nc3cc(F)ccc3c(=O)o2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.67
NPC1 O15118 5/20 0.67
RAB9A P51151 4/20 0.67
MAPT P10636 4/20 0.67
KDM4E B2RXH2 3/20 0.67
SMN1; SMN2 Q16637 3/20 0.67
LMNA P02545 1/20 0.67
HPGD P15428 3/20 0.55
KMT2A Q03164 3/20 0.53
F2 P00734 1/20 0.53
TP53 P04637 4/20 0.53
APP P05067 1/20 0.51
MAOB P27338 2/20 0.51
CTSG P08311 1/20 0.49
KLK7 P49862 1/20 0.49
CTRC Q99895 1/20 0.49
KLK14 Q9P0G3 1/20 0.49
KLK5 Q9Y337 1/20 0.49
MEN1 O00255 2/20 0.48
ELANE P08246 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17554035 0.89 ALDH1A1 (0.74) ALDH1A1NPC1RAB9AMAPTKDM4E
SCHEMBL12927374 0.89 ELANE (0.56) ALDH1A1NPC1RAB9AMAPTKDM4E
SCHEMBL9744461 0.82 ELANE (0.69) ALDH1A1NPC1RAB9AMAPTKDM4E
SCHEMBL17554019 0.81 KLK7 (0.72) ALDH1A1NPC1RAB9AMAPTKDM4E
SCHEMBL1463884 0.81 ALDH1A1 (0.75) ALDH1A1NPC1RAB9AMAPTKDM4E
SCHEMBL692625 0.81 ALDH1A1 (1.00) ALDH1A1NPC1RAB9AMAPTKDM4E
SCHEMBL29633759 0.81 ALDH1A1 (1.00) ALDH1A1NPC1RAB9AMAPTKDM4E
SCHEMBL10740589 0.80 F7 (0.60) ALDH1A1NPC1RAB9AMAPTKDM4E
SCHEMBL2537004 0.79 MAPT (0.72) ALDH1A1NPC1RAB9AMAPTKDM4E
SCHEMBL17554017 0.78 MAPT (0.66) ALDH1A1NPC1RAB9AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3628374-B1 BCL-3 INHIBITORS UNIV COLLEGE CARDIFF CONSULTANTS LTD (GB) 2023-08-30 EP disclosed
EP-3628374-B1 BCL-3 INHIBITORS UNIV COLLEGE CARDIFF CONSULTANTS LTD (GB) 2023-08-30 EP disclosed
EP-3628374-A2 BCL-3 INHIBITORS University College Cardiff Consultants Limited (GB) 2020-04-01 EP disclosed
EP-3628374-A2 BCL-3 INHIBITORS University College Cardiff Consultants Limited (GB) 2020-04-01 EP disclosed
US-20190248756-A1 BCL-3 INHIBITORS UNIV COLLEGE CARDIFF CONSULTANTS LTD (GB) 2019-08-15 US disclosed
US-20190248756-A1 BCL-3 INHIBITORS UNIV COLLEGE CARDIFF CONSULTANTS LTD (GB) 2019-08-15 US disclosed
US-10273218-B2 BCL-3 inhibitors UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2019-04-30 US disclosed
US-10273218-B2 BCL-3 inhibitors UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2019-04-30 US disclosed
US-20170267653-A1 BCL-3 INHIBITORS UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2017-09-21 US disclosed
US-20170267653-A1 BCL-3 INHIBITORS UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2017-09-21 US disclosed
US-20170267653-A1 BCL-3 INHIBITORS UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2017-09-21 US disclosed
EP-3174602-A2 BCL-3 INHIBITORS University College Cardiff Consultants Limited (GB) 2017-06-07 EP disclosed
WO-2016016728-A2 BCL-3 INHIBITORS UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2016-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190248756-A1 BCL-3 INHIBITORS BCL3, BCL2, BCL2L13 ALDH1A1 2635/4885NPC1 3070/4885RAB9A 922/4885
US-10273218-B2 BCL-3 inhibitors BCL3, BCL2, BCL2L13 ALDH1A1 2830/4885NPC1 3457/4885RAB9A 934/4885
US-20170267653-A1 BCL-3 INHIBITORS BCL3, BCL2, BCL2L13 ALDH1A1 2830/4885NPC1 3457/4885RAB9A 934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.